Director

Dr. José Baselga, MD
Director of VHIO
VALL HEBRON INSTITUTE OF ONCOLOGY
Pg. Vall Hebrón, 119-129
Edifici Maternoinfantil, planta 14
08035 Barcelona,Spain

José Baselga, MD, is the Chairman of the Medical Oncology Service at the Vall d'Hebron University Hospital in Barcelona, Spain. He is also a Professor of Medicine at the Universidad Autonoma de Barcelona. Dr. Baselga holds the position of Scientific Chairman of SOLTI, the Spanish Breast Cancer Cooperative Group.  He is a member of the Editorial Boards of Cancer Cell, Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology. Dr. Baselga has published over 200 peer-reviewed articles, in addition to over 400 abstracts and book chapters. His research interests are in Clinical Breast Cancer and in Translational and Early Clinical Research in the area of Growth Factor Receptors and Downstream Molecules as Targets for Breast Cancer Therapy. He conducted the initial clinical trials with the monoclonal antibodies cetuximab and trastuzumab. In addition, he has been involved in the clinical development of several new agents including: gefitinib, erlotinib, lapatinib, pertuzumab, m-TOR, PI3K, TGFß, SRC, Insulin-like Growth Factor Receptor Inhibitors and a variety of anti-angiogenic agents. His main focus in the laboratory and in the clinic is the area of novel anti-HER2 agents, in the identification of mechanisms of resistance to anti-HER2 agents and therapeutic approaches to target the PI3K pathway.

Dr. Baselga is currently President of the European Society of Medical Oncology (ESMO). He is a member of several Committees of the American Association for Cancer Research (AACR) and a member of the AACR Research Council and the AACR Board of Directors; a past member of the Board of Directors of the American Society of Clinical Oncology (ASCO), a past member of the Board of Directors of the European Organization of Research on Treatment of Cancer (EORTC); and a member of the Scientific Advisory Committee of the Ludwig Institute for Cancer Research.

Dr. Baselga received his M.D. degree from the Universidad Autonoma of Barcelona in 1982. He did his Internal Medicine Residency at both Vall d'Hebron University Hospital in Barcelona, Spain and the State University of New York in the US. He completed a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York and subsequently stayed on as a faculty member of the Breast Medicine Service at Memorial Sloan-Kettering until 1996 when he returned to Spain.